{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:57:37Z","timestamp":1773950257133,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fondazione Regionale per la Ricerca Biomedica POR FESR","award":["1157625"],"award-info":[{"award-number":["1157625"]}]},{"name":"Italian Ministry of University and Research (MIUR)\u2014ELIXIR-IT through the empowering project ELIXIRNextGenIT","award":["IR0000010"],"award-info":[{"award-number":["IR0000010"]}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CALabria HUB per Ricerca Innovativa ed Avanzata","award":["T4-AN-09"],"award-info":[{"award-number":["T4-AN-09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23553-3","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:05:13Z","timestamp":1763075113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic reprogramming in amyotrophic lateral sclerosis ependymal stem cells by FM19G11 nanotherapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Marco","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Bonanomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Chirizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Malacarne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Giagnorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Farinazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Porro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangelo","family":"Metrangolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Baldelli","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Gaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Marcuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"10360","key":"23553_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis [in eng]. Lancet 400 (10360), 1363\u20131380 (2022).","journal-title":"Lancet"},{"issue":"1","key":"23553_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-024-00416-x","volume":"13","author":"M Huang","year":"2024","unstructured":"Huang, M. et al. Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications [in eng]. Transl Neurodegener. 13 (1), 28 (2024).","journal-title":"Transl Neurodegener"},{"issue":"7628","key":"23553_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H. & Cleveland, D. W. Decoding ALS: from genes to mechanism [in eng]. Nature 539 (7628), 197\u2013206 (2016).","journal-title":"Nature"},{"issue":"4","key":"23553_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1089\/scd.2006.0120","volume":"16","author":"L Chi","year":"2007","unstructured":"Chi, L. et al. Temporal response of neural progenitor cells to disease onset and progression in amyotrophic lateral sclerosis-like Transgenic mice [in eng]. Stem Cells Dev. 16 (4), 579\u2013588 (2007).","journal-title":"Stem Cells Dev."},{"issue":"4","key":"23553_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/j.1471-4159.2007.04610.x","volume":"102","author":"YJ Guan","year":"2007","unstructured":"Guan, Y. J. et al. Increased stem cell proliferation in the spinal cord of adult amyotrophic lateral sclerosis Transgenic mice [in eng]. J. Neurochem. 102 (4), 1125\u20131138 (2007).","journal-title":"J. Neurochem"},{"key":"23553_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.expneurol.2013.12.007","volume":"253","author":"S Marcuzzo","year":"2014","unstructured":"Marcuzzo, S. et al. Altered MiRNA expression is associated with neuronal fate in G93A-SOD1 ependymal stem progenitor cells. Exp. Neurol. 253, 91\u2013101 (2014).","journal-title":"Exp. Neurol."},{"key":"23553_CR7","doi-asserted-by":"crossref","unstructured":"Marcuzzo, S. et al. FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice [in eng]. Cells. ;8(3). (2019).","DOI":"10.3390\/cells8030279"},{"key":"23553_CR8","doi-asserted-by":"publisher","first-page":"116380","DOI":"10.1016\/j.biopha.2024.116380","volume":"173","author":"C Malacarne","year":"2024","unstructured":"Malacarne, C. et al. FM19G11-loaded nanoparticles modulate energetic status and production of reactive oxygen species in myoblasts from ALS mice [in eng]. Biomed. Pharmacother. 173, 116380 (2024).","journal-title":"Biomed. Pharmacother"},{"issue":"10","key":"23553_CR9","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/stem.1189","volume":"30","author":"FJ Rodr\u00edguez-Jimnez","year":"2012","unstructured":"Rodr\u00edguez-Jimnez, F. J. et al. FM19G11 favors spinal cord injury regeneration and stem cell self-renewal by mitochondrial uncoupling and glucose metabolism induction [in eng]. Stem Cells. 30 (10), 2221\u20132233 (2012).","journal-title":"Stem Cells"},{"issue":"2","key":"23553_CR10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1074\/jbc.M109.008326","volume":"285","author":"V Moreno-Manzano","year":"2010","unstructured":"Moreno-Manzano, V. et al. FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status [in eng]. J. Biol. Chem. 285 (2), 1333\u20131342 (2010).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"23553_CR11","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1093\/brain\/awac025","volume":"145","author":"SA Goutman","year":"2022","unstructured":"Goutman, S. A. et al. Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts [in eng]. Brain 145 (12), 4425\u20134439 (2022).","journal-title":"Brain"},{"issue":"12","key":"23553_CR12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1136\/jnnp-2020-323611","volume":"91","author":"SA Goutman","year":"2020","unstructured":"Goutman, S. A. et al. Untargeted metabolomics yields insight into ALS disease mechanisms [in eng]. J. Neurol. Neurosurg. Psychiatry. 91 (12), 1329\u20131338 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"23553_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13578-020-00511-2","volume":"11","author":"TW Tefera","year":"2021","unstructured":"Tefera, T. W. et al. CNS glucose metabolism in amyotrophic lateral sclerosis: a therapeutic target? [in eng]. Cell. Biosci. 11 (1), 14 (2021).","journal-title":"Cell. Biosci."},{"issue":"7","key":"23553_CR14","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/ars.2009.2444","volume":"11","author":"E Foran","year":"2009","unstructured":"Foran, E. & Trotti, D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis [in eng]. Antioxid. Redox Signal. 11 (7), 1587\u20131602 (2009).","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"23553_CR15","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1111\/j.1742-4658.2009.07010.x","volume":"276","author":"S Tartari","year":"2009","unstructured":"Tartari, S. et al. Adaptation to G93Asuperoxide dismutase 1 in a motor neuron cell line model of amyotrophic lateral sclerosis: the role of glutathione [in eng]. FEBS J. 276 (10), 2861\u20132874 (2009).","journal-title":"FEBS J."},{"issue":"4","key":"23553_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/WCO.0000000000001164","volume":"36","author":"T Burg","year":"2023","unstructured":"Burg, T. & Van Den Bosch, L. Abnormal energy metabolism in ALS: a key player? [in eng]. Curr. Opin. Neurol. 36 (4), 338\u2013345 (2023).","journal-title":"Curr. Opin. Neurol."},{"key":"23553_CR17","doi-asserted-by":"publisher","first-page":"251686571882094","DOI":"10.1177\/2516865718820946","volume":"11","author":"MA Fawal","year":"2018","unstructured":"Fawal, M. A. & Davy, A. Impact of metabolic pathways and epigenetics on neural stem cells [in eng]. Epigenet Insights. 11, 2516865718820946 (2018).","journal-title":"Epigenet Insights"},{"issue":"1","key":"23553_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.expneurol.2011.05.007","volume":"231","author":"S Marcuzzo","year":"2011","unstructured":"Marcuzzo, S. et al. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study [in eng]. Exp. Neurol. 231 (1), 30\u201337 (2011).","journal-title":"Exp. Neurol."},{"key":"23553_CR19","doi-asserted-by":"crossref","unstructured":"Bonanomi, M. et al. Transcriptomics and metabolomics integration reveals Redox-Dependent metabolic rewiring in breast cancer cells [in eng]. Cancers (Basel) 13(20) (2021).","DOI":"10.3390\/cancers13205058"},{"issue":"10","key":"23553_CR20","doi-asserted-by":"publisher","first-page":"101182","DOI":"10.1016\/j.jhepr.2024.101182","volume":"6","author":"G Lori","year":"2024","unstructured":"Lori, G. et al. Altered fatty acid metabolism rewires cholangiocarcinoma stemness features [in eng]. JHEP Rep. 6 (10), 101182 (2024).","journal-title":"JHEP Rep."},{"issue":"W1","key":"23553_CR21","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between Raw spectra and functional insights [in eng]. Nucleic Acids Res. 49 (W1), W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"23553_CR22","doi-asserted-by":"publisher","first-page":"D478","DOI":"10.1093\/nar\/gkt1067","volume":"42","author":"T Jewison","year":"2014","unstructured":"Jewison, T. et al. SMPDB 2.0: big improvements to the small molecule pathway database [in eng]. Nucleic Acids Res. 42 (Database issue), D478\u2013484 (2014).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"23553_CR23","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world [in eng]. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"23553_CR24","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.4103\/1673-5374.335154","volume":"17","author":"T Lerskiatiphanich","year":"2022","unstructured":"Lerskiatiphanich, T., Marallag, J. & Lee, J. D. Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet [in eng]. Neural Regen Res. 17 (9), 1975\u20131977 (2022).","journal-title":"Neural Regen Res."},{"key":"23553_CR25","doi-asserted-by":"crossref","unstructured":"Maksimovic, K. et al. Evidence of metabolic dysfunction in amyotrophic lateral sclerosis (ALS) patients and animal models [in eng]. Biomolecules; 13(5) (2023).","DOI":"10.3390\/biom13050863"},{"issue":"7","key":"23553_CR26","doi-asserted-by":"publisher","first-page":"e21707","DOI":"10.1096\/fj.202002450R","volume":"35","author":"TS McDonald","year":"2021","unstructured":"McDonald, T. S. et al. Glucose clearance and uptake is increased in the SOD1 [in eng]. FASEB J. 35 (7), e21707 (2021).","journal-title":"FASEB J."},{"key":"23553_CR27","doi-asserted-by":"crossref","unstructured":"De Vocht, J. et al. Differences in cerebral glucose metabolism in ALS patients with and without [in eng]. Cells 12(6) (2023).","DOI":"10.3390\/cells12060933"},{"issue":"7","key":"23553_CR28","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1007\/s00259-021-05668-7","volume":"49","author":"A Canosa","year":"2022","unstructured":"Canosa, A. et al. Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes [in eng]. Eur. J. Nucl. Med. Mol. Imaging. 49 (7), 2242\u20132250 (2022).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"10","key":"23553_CR29","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1001\/jamaneurol.2014.1584","volume":"71","author":"JM Pascual","year":"2014","unstructured":"Pascual, J. M. et al. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement [in eng]. JAMA Neurol. 71 (10), 1255\u20131265 (2014).","journal-title":"JAMA Neurol."},{"issue":"5","key":"23553_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ana.410220503","volume":"22","author":"A Plaitakis","year":"1987","unstructured":"Plaitakis, A. & Caroscio, J. T. Abnormal glutamate metabolism in amyotrophic lateral sclerosis [in eng]. Ann. Neurol. 22 (5), 575\u2013579 (1987).","journal-title":"Ann. Neurol."},{"issue":"31","key":"23553_CR31","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.2174\/0929867321666140916120118","volume":"21","author":"H Blasco","year":"2014","unstructured":"Blasco, H. et al. The glutamate hypothesis in ALS: pathophysiology and drug development [in eng]. Curr. Med. Chem. 21 (31), 3551\u20133575 (2014).","journal-title":"Curr. Med. Chem."},{"key":"23553_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fnins.2015.00469","volume":"9","author":"J Lewerenz","year":"2015","unstructured":"Lewerenz, J. & Maher, P. Chronic glutamate toxicity in neurodegenerative Diseases-What is the evidence? [in eng]. Front. Neurosci. 9, 469 (2015).","journal-title":"Front. Neurosci."},{"key":"23553_CR33","doi-asserted-by":"crossref","unstructured":"Arnold, F. J. et al. Revisiting glutamate excitotoxicity in amyotrophic lateral sclerosis and Age-Related neurodegeneration [in eng]. Int. J. Mol. Sci.; 25(11), 5587 (2024).","DOI":"10.3390\/ijms25115587"},{"key":"23553_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2016.11.064","volume":"649","author":"LA Averill","year":"2017","unstructured":"Averill, L. A. et al. Glutamate dysregulation and glutamatergic therapeutics for PTSD: evidence from human studies [in eng]. Neurosci. Lett. 649, 147\u2013155 (2017).","journal-title":"Neurosci. Lett."},{"issue":"10","key":"23553_CR35","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1158\/1535-7163.MCT-20-0006","volume":"19","author":"XM Wang","year":"2020","unstructured":"Wang, X. M. et al. Dysregulation of EAAT2 and VGLUT2 spinal glutamate transports via histone deacetylase 2 (HDAC2) contributes to Paclitaxel-induced painful neuropathy [in eng]. Mol. Cancer Ther. 19 (10), 2196\u20132209 (2020).","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"23553_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","volume":"48","author":"SC Barber","year":"2010","unstructured":"Barber, S. C. & Shaw, P. J. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target [in eng]. Free Radic Biol. Med. 48 (5), 629\u2013641 (2010).","journal-title":"Free Radic Biol. Med."},{"key":"23553_CR37","doi-asserted-by":"crossref","unstructured":"Kim, K. Glutathione in the nervous system as a potential therapeutic target to control the development and progression of amyotrophic lateral sclerosis [in eng]. Antioxid. (Basel) 10(7), 1011 (2021).","DOI":"10.3390\/antiox10071011"},{"key":"23553_CR38","doi-asserted-by":"publisher","first-page":"5021694","DOI":"10.1155\/2020\/5021694","volume":"2020","author":"T Cunha-Oliveira","year":"2020","unstructured":"Cunha-Oliveira, T. et al. Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for Pharmacological intervention [in eng]. Oxid. Med. Cell. Longev. 2020, 5021694 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1\u20132","key":"23553_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","volume":"30","author":"HJ Forman","year":"2009","unstructured":"Forman, H. J., Zhang, H. & Rinna, A. Glutathione: overview of its protective roles, measurement, and biosynthesis [in eng]. Mol. Aspects Med. 30 (1\u20132), 1\u201312 (2009).","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"23553_CR40","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuroscience.2009.09.006","volume":"164","author":"LK Hamilton","year":"2009","unstructured":"Hamilton, L. K. et al. Cellular organization of the central Canal ependymal zone, a niche of latent neural stem cells in the adult mammalian spinal cord [in eng]. Neuroscience 164 (3), 1044\u20131056 (2009).","journal-title":"Neuroscience"},{"key":"23553_CR41","doi-asserted-by":"publisher","first-page":"670756","DOI":"10.1155\/2014\/670756","volume":"2014","author":"F Fornai","year":"2014","unstructured":"Fornai, F. et al. Plastic changes in the spinal cord in motor neuron disease [in eng]. Biomed. Res. Int. 2014, 670756 (2014).","journal-title":"Biomed. Res. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23553-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:05:15Z","timestamp":1763075115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23553-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23553"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23553-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were carried out in accordance with the EU Directive 2010\/63 and with the Italian law (D.L. 26\/2014) on the protection of animals used for scientific purposes. Transgenic G93A-SOD1 (B6SJL-Tg (SOD1*G93A)1Gur\/J) [MGI: 2183719] and control B6.SJL mice were purchased from Charles River Laboratories, Inc. (Wilmington, MA, USA), maintained and bred at the animal house of the Fondazione IRCCS Istituto Neurologico Carlo Besta in compliance with institutional guidelines. The project was approved by the Ethics Committee of the Institute and the Italian Ministry of Health (ref. 78\/2022-PR, \u201cMalattie del motoneurone: studio di microRNA in modelli sperimentali per l\u2019ottimizzazione della diagnosi e l\u2019identificazione di potenziali trattamenti terapeutici\u201d).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"39847"}}